• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTERVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTERVASCULAR CATHETER Back to Search Results
Catalog Number 382534
Device Problems Retraction Problem (1536); Sticking (1597)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/01/2018
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the retraction feature of the bd insyte¿ autoguard¿ bc shielded iv catheter has had off and on issues of the retraction button sticking during use.No reports of serious injury or medical intervention noted.
 
Manufacturer Narrative
Due to an it issue beginning on (b)(6) 2018, previously filed emdrs did not contain required fields.This supplemental emdr is filed to provide the following omitted fields: device returned to manufacture: yes.
 
Event Description
It was reported that the retraction feature of the bd insyte autoguard bc shielded iv catheter has had off and on issues of the retraction button sticking during use.No reports of serious injury or medical intervention noted.
 
Manufacturer Narrative
H.6.Investigation summary: lot 7323650 was provided, yet it is not a lot number for material 382534.Correct lot number 7223650.Device/batch history record review was performed on the lot number: 7223650.The product was built on afa line 11, from august 17, 2017 thru august 21, 2017.Review of the dhr revealed all required challenges samples and testing was performed per specification in accordance with the setup and in-process sampling plans.Setup and in-process samples for needle retraction by button activation were performed on various stages throughout the process, all the inspections passed per specifications.No significant discoveries were found.Qn / sap database review findings: there were no reject activity findings relevant to the defect stated in the pir associated with the lot number provided for this incident.The peura (end user risk analysis) was analyzed to determine the risk to customer.The analysis showed that due to low occurrence, current risk is acceptable.Observations and testing: received two iag /bc 20ga units from the lot number 7223650.One unit was used and taped to the paper top web (unit label).One was unused and in a sealed package.Visual/microscopic examination: used unit: the needle was not retracted, and the white button was not depressed.Observed there was no mechanical/physical damage to any of the components (spring, needle hub, grips) or evidence of adhesive on the button or hub.Unused unit: removed from sealed unit package for evaluation.Observed there was no mechanical/physical damage to any of the components (spring, needle hub, grips) or evidence of adhesive on the button or hub.Functional test (needle retraction) was performed: performed the hub twist test on both units then depressed the buttons.The retraction was successful, no delayed reaction was observed.Conclusions: the defect needle retraction failure, as stated in the description of the complaint, was not confirmed with the returned units.The returned units did not display any adverse characteristics that would contribute to the reported defect.The defect described in the incident report could not be confirmed or replicated with the returned units.There was no definite physical or mechanical evidence that confirmed and supported manufacturing process related issues for the defect observed in this incident.A formal corrective action will not be initiated at this time.A manufacturing related root cause could not be identified.Customer complaint trends are evaluated monthly.If the trend of a specific type of complaint warrants a formal corrective action, resources will be assigned at that time.
 
Event Description
It was reported that the retraction feature of the bd insyte¿ autoguard¿ bc shielded iv catheter has had off and on issues of the retraction button sticking during use.No reports of serious injury or medical intervention noted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER
Type of Device
INTERVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key7530136
MDR Text Key109012602
Report Number1710034-2018-00231
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00382903825349
UDI-Public00382903825349
Combination Product (y/n)N
PMA/PMN Number
K110443
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup,Followup
Report Date 08/24/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date07/31/2020
Device Catalogue Number382534
Device Lot Number7223650
Initial Date Manufacturer Received 05/03/2018
Initial Date FDA Received05/21/2018
Supplement Dates Manufacturer Received05/03/2018
05/03/2018
Supplement Dates FDA Received07/19/2018
10/02/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-